Lyell Immunopharma, Inc.
LYEL • NASDAQ • Stock Fundamentals
Lyell Immunopharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lynn Seely, with a market cap of $320.1M.
Market Cap$320.1M
Employees224.0
CEOLynn Seely
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Lyell Immunopharma, Inc. FAQ
Common questions about Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. (LYEL) has a market capitalization of $320.1M and trades on NASDAQ.
Lyell Immunopharma, Inc. has approximately 224 employees.